Almeda-Valdés P, Pichardo-Bahena R

Language: Spanish
References: 13
Page: 115-121
PDF size: 78.35 Kb.

ABSTRACT

The cancer of unknown primarily site is a difficult diagnosis for the clinician and pathologist. In many cases the primarily site is not identified. It is necessary to establish a cost-benefit strategy to the study theses patients. The immunohistochemistry has a very important role in the diagnosis of the primarily site. The objectives of this review are the definition of terms, diagnostic methods and the prognosis of the patients with cancer of unknown primarily site.

REFERENCES

1. Briasoulis E, Pavlidis N. Cancer of unknown primary origin. The Oncologist. 1997; 2: 142-152.

2. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Eng J Med 1993; 324: 257-263.

3. De Yong B, Wick MR. Immunohistologic evaluation of metastasic carcinomas of unknown origin: An algorithmic approach. Seminars in Diagnostic Pathology 2000; 17: 184-193.

4. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected tumours of unknown origin. J Clin Oncol 1995; 13: 2094-2103.

5. Le Chevalier T, Cvitkovic E, Caille P, Harvey J, Contesso G, Spielmann M, Rouesse J. Early metastatic cancer of unknown primary origin at presentation: a clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988; 148: 2035-2039.

6. Hamilton CS, Langlands AO. ACUPS (adenocarcinoma of unknown primary site): a clinical and cost benefit analysis. Int J Radiat Oncol Biol Phys 1987; 13: 1497-1503.

7. Kirsten F, Chi CH, Leary JA, Ng AB, Hedley DW, Tattersall MH. Metastatic adeno or undifferentiated carcinoma from an unknown primary site-natural history and guidelines for identification of treatable subsets. Q J Med 1987; 62: 143-161.

8. Nystrom JS, Weiner JM, Wolf RM, Bateman JR, Viola MV. Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA 1979; 241: 381-383.

9. Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG. Treatment of the patient with adenocarcinoma of unknown origin. Cancer 1972; 30: 1469-1472.

10. Osteen RT, Kopf G, Wilson RE. In pursuit of the unknown primary. Am J Surg 1978; 135: 494-498.

11. Pavlidis N, Kalef-Ezra J, Briassoulis E, Skarlos D, Kosmidis P, Saferiadis K, Bairaktari E, Bafaloukos D, Maravegias A, Theoharis D. Evaluation of six tumor markers in patients with carcinoma of unknown primary. Med Pediatr Oncol 1994; 22: 162-167.

12. Rhess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Classification and regression tree analysis of 1,000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 1999; 5: 3403-3410.

13. Culine S, Kramar A, Saghatchian M, Bugat R, Resimple T, Lortholary L, Merrouche Y, Laplanche A, Fizazi K. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 2002; 20: 4679-4683.